Lynwood Capital Management’s Immix Biopharma IMMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $1.24M | Buy |
+405,000
| New | +$1.24M | 7.37% | 5 |
|
|
2023
Q3 | – | Sell |
-200,250
| Closed | -$539K | – | 93 |
|
|
2023
Q2 | $539K | Buy |
+200,250
| New | +$539K | 0.68% | 49 |
|
|
2023
Q1 | – | Sell |
-25,000
| Closed | -$58K | – | 133 |
|
|
2022
Q4 | $58K | Buy |
+25,000
| New | +$58K | 0.07% | 89 |
|
|
2022
Q1 | – | Sell |
-565,297
| Closed | -$2.01M | – | 143 |
|
|
2021
Q4 | $2.01M | Buy |
+565,297
| New | +$2.01M | 1.93% | 12 |
|